Wordt geladen...
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
BACKGROUND: Currently no effective antiviral therapy has been found to treat COVID-19. The aim of this trial was to assess if the addition of sofosbuvir and daclatasvir improved clinical outcomes in patients with moderate or severe COVID-19. METHODS: This was an open-label, multicentre, randomized c...
Bewaard in:
| Gepubliceerd in: | J Antimicrob Chemother |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7454592/ https://ncbi.nlm.nih.gov/pubmed/32812039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa334 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|